Dear Colleagues, Interasma Scientific Network (INES) invite you to complete this survey, leaded by Prof. Angelica Tiotiu which aims to “identify 5 criteria to use in practice for the evaluation of the response to biologics in asthma at 4 months of treatment”. Compilation takes a maximum of 5 minutes and your choices will be anonymous unless you will select to be involved in the scientific dissemination. Contact e-mail: inesnetwork@interasma.org Your participation in this study is completely voluntary. If you choose to participate, you may choose to discontinue participation at any time, and you may choose any of the survey questions that you do not wish to answer. Your completion of the survey must be made until August 8th, 2022. Sincerely,Angelica Tiotiu MD PhD, Pulmonologist, Allergologist in the Department of Pulmonology, University Hospital of Nancy, France |
Recent Posts
- 17q21 Variants Disturb Mucosal Host Defense in Childhood Asthma
- TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
- New for Journal of Asthma online now on Taylor & Francis Online
- The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma
- Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-asthma Biologics